Year II · No. 665 · 1,823 entries Tuesday, October 27, 2026 ES EN Get the weekly digest

US · 4 entries · 4 publications

PFE

Pfizer

Entries
4
Bullish
1
Bearish
1
First
Feb 28, 2025
Latest
Jul 27, 2026

▲ 1 bullish ▼ 1 bearish · 2 no stance

As many bullish as bearish among those that state a stance.

Jan 25 – Oct 26 · per month

Full performance tracking Pro · free during launch

Alpha of every thesis on PFE at 1, 3 and 6 months and since publication, and the full chart vs its benchmark.

Free during launch: log in or sign up with your email to see it.

Sign up free

Timeline

Newest to oldest
  1. July 2026 1 entry

    Substack · The Inside Analyst · Niklas Petry

    Pfizer Looks Cheap And Safe. So Why Is It Still a Poor Investment?

    Value investing is about finding cheap stocks - but there are common pitfalls. The Financial X-Ray reveals why low valuation and low predictability often go hand in hand.

    BullishPFEshort996 words

    Since publication +20.8% α +17.2 pp vs S&P 500 · USD

  2. November 2025 1 entry
  3. June 2025 1 entry
  4. February 2025 1 entry

    Substack · Devil Investor´s Substack · Devil Investors

    PFIZER

    "La montaña rusa de Pfizer: cómo la era COVID-19 transformó y ahora desafía sus ingresos."

    PFEES5,746 words

    Since publication +12.7% α −16.2 pp vs S&P 500 · USD

There are 3 more low-confidence entries, hidden because the ticker could not be checked in the text. See them in the index →

Prices as of the Oct 27, 2026 close. Past performance does not guarantee future results. Price-only, excluding dividends, in local currency. Data may be delayed or inaccurate. Not investment advice. How it is calculated.